BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 124 filers reported holding BLUEBIRD BIO INC in Q3 2014. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $236,000 | -27.8% | 2,570 | 0.0% | 0.12% | -32.0% |
Q2 2019 | $327,000 | -22.1% | 2,570 | -3.7% | 0.17% | -24.6% |
Q1 2019 | $420,000 | +61.5% | 2,670 | +1.9% | 0.22% | +40.9% |
Q4 2018 | $260,000 | -47.9% | 2,620 | -23.4% | 0.16% | -35.4% |
Q3 2018 | $499,000 | -7.1% | 3,420 | 0.0% | 0.25% | -14.6% |
Q2 2018 | $537,000 | -13.1% | 3,420 | -5.5% | 0.29% | -13.5% |
Q1 2018 | $618,000 | +7.7% | 3,620 | +12.4% | 0.33% | +14.8% |
Q4 2017 | $574,000 | +26.2% | 3,220 | -2.7% | 0.29% | +21.3% |
Q3 2017 | $455,000 | +53.7% | 3,310 | +17.3% | 0.24% | +45.7% |
Q2 2017 | $296,000 | +22.3% | 2,822 | +6.1% | 0.16% | +18.8% |
Q1 2017 | $242,000 | +47.6% | 2,660 | 0.0% | 0.14% | +36.6% |
Q4 2016 | $164,000 | -31.1% | 2,660 | -24.2% | 0.10% | -32.7% |
Q3 2016 | $238,000 | +56.6% | 3,510 | 0.0% | 0.15% | +51.5% |
Q2 2016 | $152,000 | +2.7% | 3,510 | +0.4% | 0.10% | -1.0% |
Q1 2016 | $148,000 | -33.9% | 3,495 | +0.3% | 0.10% | -33.3% |
Q4 2015 | $224,000 | -39.1% | 3,485 | -19.0% | 0.15% | -45.5% |
Q3 2015 | $368,000 | -38.7% | 4,305 | +20.8% | 0.28% | -33.1% |
Q2 2015 | $600,000 | +201.5% | 3,565 | +116.7% | 0.41% | +195.7% |
Q1 2015 | $199,000 | +2111.1% | 1,645 | +1545.0% | 0.14% | +1885.7% |
Q4 2014 | $9,000 | +125.0% | 100 | 0.0% | 0.01% | +133.3% |
Q3 2014 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | +50.0% |
Q2 2014 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |